Best first-line therapy for patients with advanced non-small cell lung cancer, performance status 2 without a targetable mutation
| Autor: | R G Gijtenbeek, K De Jong, B J Venmans, F Van Vollenhoven, A J Van Der Wekken, W H Van Geffen |
|---|---|
| Rok vydání: | 2022 |
| Zdroj: | 11.01 - Lung cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|